$174 Million is the total value of Vantage Consulting Group Inc's 216 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -26,067 | -100.0% | -0.01% | – |
GCI | Exit | GANNETT CO INC | $0 | – | -10,680 | -100.0% | -0.01% | – |
K | Exit | KELLOGG CO | $0 | – | -2,991 | -100.0% | -0.11% | – |
IEX | Exit | IDEX CORP | $0 | – | -868 | -100.0% | -0.11% | – |
RSG | Exit | REPUBLIC SVCS INC | $0 | – | -1,502 | -100.0% | -0.12% | – |
GLW | Exit | CORNING INC | $0 | – | -5,738 | -100.0% | -0.12% | – |
XYL | Exit | XYLEM INC | $0 | – | -1,930 | -100.0% | -0.12% | – |
PEP | Exit | PEPSICO INC | $0 | – | -1,110 | -100.0% | -0.12% | – |
HSY | Exit | HERSHEY CO | $0 | – | -805 | -100.0% | -0.12% | – |
APH | Exit | AMPHENOL CORP NEWcl a | $0 | – | -2,496 | -100.0% | -0.12% | – |
ROL | Exit | ROLLINS INC | $0 | – | -5,505 | -100.0% | -0.12% | – |
CTAS | Exit | CINTAS CORP | $0 | – | -445 | -100.0% | -0.12% | – |
MMM | Exit | 3M CO | $0 | – | -1,955 | -100.0% | -0.12% | – |
MDLZ | Exit | MONDELEZ INTL INCcl a | $0 | – | -2,945 | -100.0% | -0.12% | – |
WM | Exit | WASTE MGMT INC DEL | $0 | – | -1,277 | -100.0% | -0.12% | – |
HAS | Exit | HASBRO INC | $0 | – | -3,881 | -100.0% | -0.12% | – |
FFIV | Exit | F5 INC | $0 | – | -1,470 | -100.0% | -0.12% | – |
DIS | Exit | DISNEY WALT CO | $0 | – | -2,174 | -100.0% | -0.12% | – |
DISH | Exit | DISH NETWORK CORPORATIONcl a | $0 | – | -24,157 | -100.0% | -0.13% | – |
ANET | Exit | ARISTA NETWORKS INC | $0 | – | -1,391 | -100.0% | -0.13% | – |
GIS | Exit | GENERAL MLS INC | $0 | – | -2,776 | -100.0% | -0.14% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-11
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ROYALTY PHARMA PLC | 12 | Q3 2023 | 87.5% |
ADC THERAPEUTICS SA SHS | 12 | Q3 2023 | 9.8% |
FIBROGEN INC | 12 | Q3 2023 | 5.7% |
COSTCO WHSL CORP NEW | 12 | Q3 2023 | 0.5% |
WALMART INC | 12 | Q3 2023 | 0.5% |
Sysco Corporation | 12 | Q3 2023 | 0.5% |
Exxon Mobil Corporation | 12 | Q3 2023 | 0.5% |
Chevron Corporation | 12 | Q3 2023 | 0.5% |
KROGER CO | 12 | Q3 2023 | 0.5% |
CVS Health Corporation | 12 | Q3 2023 | 0.5% |
View Vantage Consulting Group Inc's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
SYNTAX ETF TRUST | September 11, 2023 | 717,132 | 52.2% |
SYNTAX ETF TRUST | November 08, 2022 | 156,133 | 56.8% |
SYNTAX ETF TRUSTSold out | June 24, 2021 | 0 | 12.4% |
View Vantage Consulting Group Inc's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
SC 13G/A | 2023-09-11 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-10 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
SC 13G/A | 2022-11-08 |
SC 13G/A | 2022-10-04 |
View Vantage Consulting Group Inc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.